Real-time enrollment status for this leukemia, myelomonocytic, chronic clinical trial
Current Status
Recruiting
Checked: October 17, 2026 at 4:38 AM UTC
| NCT Number | NCT07033598 |
| Recruiting Status | Recruiting |
| Condition | Leukemia, Myelomonocytic, Chronic |
| Phase | PHASE2 |
| Target Enrollment | 66 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Theradex |
| Last Updated on CT.gov | August 18, 2026 (Aug 18, 2026) |
As of October 17, 2026: Clinical trial NCT07033598 is currently recruiting participants. This phase2 study for leukemia, myelomonocytic, chronic is actively seeking new participants at 4 locations across the United States. The study is sponsored by Theradex. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07033598 is actively recruiting participants as of October 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07033598 was last updated Aug 18, 2026 (August 18, 2026). HelloStudys verifies this status automatically.